## AIZ: Assurant, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 -0.3% below STRENGTH zone (3.0-6.0%); PEG 1.46 fails VALUE criteria (<1.0); RSI 72 overbought. Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.8% MRS), overbought RSI (72).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($232.34)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Thinking of Adding CNO Financial? Here's What Stands Out**
- Source: TradingView â€” Track All Markets | 20251226T170929 | Somewhat-Bullish | Relevance: 62%
- CNO Financial Group, Inc. (CNO) is positioned for growth due to strong premiums from various insurance products, increasing new annualized premiums, and higher fee revenues, supported by industry trends and technology investments. The company, a Zacks Rank #2 (Buy) stock, shows promising earnings forecasts and a strong return on invested capital. Despite a high debt-to-capital ratio and declining cash, its strategic plans and shareholder returns indicate continued long-term growth potential.

**2. Planned Chubb AI overhaul places 20% of jobs at risk**
- Source: Insurance Times | 20251224T072719 | Neutral | Relevance: 61%
- Chubb plans to cut approximately 20% of its global workforce, impacting 8,500 to 9,000 roles, over the next three to four years as part of a major digital transformation focused on AI and automation. This initiative aims to automate 85% of major underwriting and claims processes and generate 85% of global gross written premium digitally, positioning the insurer for an anticipated soft market. The company also projects its private investments to grow from $0.9bn to around $2bn.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | Piper Sandler | $264 | $252 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | Piper Sandler | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 2 ($0.10M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 55.5% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 1 / 9 |

**Top Holders:**
- Vanguard Group Inc: 13.2% (-2.0%)
- Bank Of New York Mel: 10.0% (+23.7%)
- Blackrock Inc.: 7.9% (-0.4%)
- T. Rowe Price Invest: 7.7% (-3.5%)
- State Street Corpora: 5.4% (-3.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.46 suggests fair value with growth premium. Balance sheet: strong liquidity (11492000000.0x). Institutional flow bearish (9 selling vs 1 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $12.1B |
| Beta | 0.57 |
| 52W Range | $174.97 - $243.75 |
| Short Interest | 2.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.46 |
| Forward P/E | 11.5 |
| Current P/E | 12.3 |
| YoY Growth | 6.8% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 3.5% to -0.3% (-3.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.3pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.03), confirming momentum. RSI overbought at 72, risk of mean reversion. OFD pattern: -SUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.28% (CS: 66) | Neutral |
| RSI_14 | 71.5 | Overbought |
| MACD Histogram | 1.03 | Bullish |
| vs SMA20 | 1.041x | Above |
| vs SMA50 | 1.076x | Above |
| vs SMA200 | 1.159x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $240.26
- **Stop Loss:** $232.34 (3.3% risk)
- **Target:** $248.18 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 166
- **Position Value:** $39,883.16
- **Portfolio %:** 39.88%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-02-10 (Est: $5.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.28 | $5.73 | +34.0% |
| 2025Q2 | $4.45 | $5.10 | +14.5% |
| 2025Q1 | $2.78 | $3.39 | +22.1% |
| 2024Q4 | $4.13 | $4.79 | +15.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*